Frequently Asked Questions

503A refers to a section of the Federal Food, Drug, and Cosmetic Act that allows licensed pharmacies to prepare compounded medications pursuant to a valid patient-specific prescription. Compounded medications are prepared to meet the needs of an individual patient when a commercially available product is not appropriate for that patient.

SmartPharmaRX compounds sterile preparations in accordance with applicable USP standards and state board of pharmacy requirements. Quality systems include environmental monitoring, qualified cleanroom facilities, standardized compounding procedures, quality assurance processes and sterility and endotoxin testing when applicable.

Compounded medications are prepared pursuant to a valid patient-specific prescription and individualized treatment plan. While formulations may be customized based on a patient’s clinical needs, all preparations are compounded using standardized procedures, quality controls and applicable regulatory requirements designed to support consistency and product integrity.

Compounded medications are prescription preparations created by a licensed pharmacist to meet the specific needs of an individual patient when commercially available products are not appropriate or available. Compounded medications are prepared pursuant to a valid patient-specific prescription and are not FDA-approved products.

SmartPharmaRX maintains administrative, technical and physical safeguards designed to protect patient information and prescription records. Access to patient information is limited to authorized personnel and managed in accordance with applicable privacy and security requirements.

SmartPharmaRX follows applicable USP compounding standards and state board of pharmacy requirements. Additional standards may apply depending on the type of preparation and applicable regulations.

Quality control procedures may include sterility testing, endotoxin testing, environmental monitoring, ingredient verification and other quality assurance activities as appropriate for the preparation being compounded. Testing protocols vary based on the formulation and applicable regulatory requirements.

SmartPharmaRX dispenses medications only in states where it is appropriately licensed and authorized to do so. Please refer to our Licensing page for the most current list of licensed states, pending applications and service availability.

Compounding and dispensing regulations vary by state. SmartPharmaRX only dispenses medications in states where it is appropriately licensed and where the prescribed medication may be dispensed in accordance with applicable state and federal requirements.

Once a valid prescription is received, our pharmacy team reviews the order, verifies the required information and prepares the prescription in accordance with applicable quality and regulatory requirements. Patients and providers may be contacted if additional information is needed before processing can be completed.

Shipping availability is limited to states where SmartPharmaRX is licensed and authorized to dispense medications. Shipping methods, delivery timelines and product availability may vary based on state requirements, prescription details and applicable regulations.

SmartPharmaRX can only dispense medications in states where the appropriate licensure requirements have been met. If your state is currently pending licensure, medications cannot be dispensed until all applicable licensing requirements have been satisfied.

Tirzepatide and Semaglutide are different active pharmaceutical ingredients that may be prescribed by licensed healthcare providers as part of a patient-specific treatment plan. Healthcare providers determine whether a particular therapy is appropriate for an individual patient based on clinical considerations.

Compounded GLP-1 therapies are prepared only pursuant to a valid patient-specific prescription from a licensed healthcare provider. Prescriptions may be submitted through an approved electronic prescribing system in accordance with applicable state and federal requirements.

Healthcare providers seeking product information may be asked to provide practice information and licensing credentials. Additional information may be required depending on the nature of the request and applicable regulatory requirements.